Switching ADHD Stimulants: What Your Prescriber Needs to See
A structured before-and-after report template for switching ADHD stimulants — from Ritalin to Concerta, Concerta to Vyvanse/Elvanse, or any other change.
Get new titration guides by email
Occasional, evidence-based guides on medication tracking and titration — no noise.
Disclaimer: This article provides general educational guidance on switching ADHD stimulants. Every switch should be planned and supervised by your licensed prescriber. Never stop, start, or combine medications without explicit medical direction.
Switching ADHD stimulants is common. The first stimulant you try is not always the right one: side effects may be too strong, the effect curve may not fit your day, or the benefits may plateau below what you need. A switch is not a failure — it's a normal part of titration.
What makes a switch successful is usually not the new medication itself. It's the data you bring to the decision. This guide covers the common reasons to switch, how to compare medications during the transition, and the exact report template that gives your prescriber a clear before-and-after picture.
Why people switch stimulants
Stimulants fall into two main classes: methylphenidate-based (Concerta, Ritalin, Medikinet, Equasym) and amphetamine-based (Vyvanse/Elvanse, Adderall, Dexedrine). A large 2018 network meta-analysis found medicines from both classes effective, and it favored methylphenidate for children and adolescents and amphetamines for adults as first choices for short-term treatment [1]. Even so, NICE notes that the size of the effect, how long it lasts and the side effects of stimulants vary from person to person [2].
Common reasons for switching include:
| Reason | A question to bring to your prescriber | What to log |
|---|---|---|
| Side effects too strong | Would a different formulation or dose be an option? | When each side effect starts and peaks |
| Effect too short | Is there a way to cover more of my day? NICE mentions pairing a morning long-acting methylphenidate with a short-acting dose later [2] | The time the effect fades |
| Rebound too severe | Would a different release profile fit better? | When the crash starts and how long it lasts |
| Appetite/weight loss | Could a dose or medication change help? NICE lists changing medication among the options [2] | Meals eaten, and weight if you track it |
| Sleep disruption | Could the timing change? The Vyvanse and Adderall XR labels advise against afternoon doses because of insomnia [3][4] | Dose time, bedtime and sleep onset |
| Anxiety or jitteriness | Is this expected at this dose, or a reason to change? | When it peaks, and how strong it is |
| Insurance/pharmacy availability | Can a specific product be named on the prescription? | Product name, manufacturer and the date it changed |
A switch within the same class (e.g., Concerta to Ritalin LA) is often about finding a release profile that fits your day. A switch across classes (e.g., methylphenidate to amphetamine) is often about finding a different side-effect/benefit balance.
The washout question: do you need to stop the old one first?
The short answer is: follow your prescriber's instructions exactly. There is no universal rule.
The Vyvanse and Concerta labels don't set a waiting period for moving from one stimulant to another. The firm rule they do set is about a different drug group: neither may be taken with an MAOI or within 14 days of stopping one (most MAOIs are antidepressants, and the Vyvanse label also names linezolid and IV methylene blue) [3][5]. The Concerta label also gives starting doses for people coming from immediate-release methylphenidate [5].
Some prescribers start the new medication the next day; others build in a gap, for example if the previous medication caused insomnia, anxiety or heart symptoms. A gap gives you a short unmedicated baseline, but it also means time without medication, which may not suit work or school.
The key is to document the transition. Even a short washout gives you useful baseline data: how do you sleep, eat, and focus without medication? That baseline makes the new medication's effect easier to judge.
What to track during a stimulant switch
A switch is a natural experiment. To make it useful, you need comparable data before and after. Track the same variables on both medications so your prescriber can see what changed.
Core daily metrics
| Metric | How to track | Why it matters |
|---|---|---|
| Dose and time | Exact mg and time taken | Different medications have different timing rules |
| Focus | 1–5 scale at 9 AM, 1 PM, 5 PM | Captures the curve, not just the peak |
| Energy/motivation | 1–5 scale at same times | Distinguishes true benefit from mere activation |
| Irritability/anxiety | 1–5 scale | Side effect that may change with class or dose |
| Appetite | 1–5 scale or meal notes | Decreased appetite is among the most common side effects on stimulant labels [3][4][5] |
| Sleep | Onset, total hours, quality | Insomnia is also a common label side effect [3][4] |
| Cardiovascular | Resting HR/BP if you have a cuff | NICE asks for heart rate and blood pressure checks before and after each dose change [2] |
| Functional notes | 1–2 sentences | "Completed project X" or "avoided all calls" |
Weekly summary questions
At the end of each week on the new medication, answer these in one sentence each:
- Is my focus better, worse, or the same compared to the previous medication?
- Is my sleep better, worse, or the same?
- Is my appetite better, worse, or the same?
- What is my best time of day on this medication?
- What is my worst time of day on this medication?
- Is the side-effect/benefit trade-off better or worse?
- What do I want to ask my prescriber about next?
The stimulant switch report template
Bring this one-page format to your prescriber. It is designed to be scannable in under 60 seconds.
Stimulant Switch Report
Patient name: ___________________
Date range: ___________________
Old medication: ___________________
New medication: ___________________
Dose comparison
| Old medication | New medication | |
|---|---|---|
| Dose | ||
| Time taken | ||
| Days tracked |
Average ratings (1–5 scale)
| Symptom / metric | Old (avg) | New (avg) |
|---|---|---|
| Morning focus | ||
| Afternoon focus | ||
| Evening focus | ||
| Motivation | ||
| Irritability | ||
| Anxiety | ||
| Appetite | ||
| Sleep quality | ||
| Energy rebound/crash |
Functional comparison
| Area | Old medication | New medication |
|---|---|---|
| Work/school productivity | ||
| Home responsibilities | ||
| Social interactions | ||
| Exercise/physical activity |
Side effects checklist
| Side effect | Old | New |
|---|---|---|
| Reduced appetite | □ worse □ same □ better | □ worse □ same □ better |
| Insomnia | □ worse □ same □ better | □ worse □ same □ better |
| Headache | □ worse □ same □ better | □ worse □ same □ better |
| Dry mouth | □ worse □ same □ better | □ worse □ same □ better |
| Anxiety/jitteriness | □ worse □ same □ better | □ worse □ same □ better |
| Heart racing / palpitations | □ worse □ same □ better | □ worse □ same □ better |
| Rebound / crash | □ worse □ same □ better | □ worse □ same □ better |
What I'd like to discuss
□ How the new medication is going at this dose
□ Whether the dose is right
□ Whether a different medication is worth considering
□ Other: ___________________
Questions for my prescriber
This template works because it turns a subjective experience into a structured comparison. Your prescriber can see at a glance whether the switch solved the problem or created new ones.
Special scenarios
Switching from Ritalin IR to Concerta
The usual goal is to move from several daily doses to a single morning dose. The Concerta label gives a starting dose based on the immediate-release regimen you were on, and it describes a first peak about 1 hour after the dose with the highest level at 6 to 10 hours [5]. Log at the same times you used before so you can compare the shape of the day. Some people miss the flexibility of separate doses.
Switching from Concerta to Vyvanse/Elvanse
This is a common cross-class switch. NICE describes it as an option for adults when a 6-week trial of methylphenidate at an adequate dose hasn't helped enough [2]. Vyvanse is a prodrug that the body converts to d-amphetamine; its label puts peak blood levels at about 3.5 to 4 hours, and in an adult study the effect was measured from 2 to 14 hours after the dose [3]. People describe the change differently, so your own log matters more than anyone else's report.
Switching from Vyvanse/Elvanse to methylphenidate
Some adults find Vyvanse/Elvanse lasts too long into the evening or affects appetite too much. NICE describes switching to methylphenidate for adults when a 6-week trial of lisdexamfetamine at an adequate dose hasn't helped enough [2]. Track sleep, appetite and the time the effect fades on both, so the comparison is fair.
Switching due to generics or supply issues
If your pharmacy switches you to a different generic, some people notice a difference. Track the same metrics you would for a medication switch. If you notice a meaningful change, tell your prescriber and ask whether a specific formulation can be specified on the prescription.
What your prescriber needs to see
The most useful thing you can bring is not a long narrative. It's a before-and-after comparison. Specifically, your prescriber wants to know:
- Did the switch solve the problem that motivated it?
- Did it create any new problems?
- Is the side-effect/benefit trade-off better?
- Is the dose right, or does it need adjustment?
- Is the timing right?
The report template above gives exactly that. The more structured your data, the less time your prescriber spends reconstructing your experience from memory and the more time they spend on the decision.
Generate your switch report with Titrate
Switching medications is one of the most important times to track. Without data, you and your prescriber are comparing two fuzzy memories. With data, the comparison becomes a clear clinical signal.
Titrate is built for this. Daily check-ins capture dose, timing, effect, and side effects. At the end of a week, Titrate produces a structured comparison report — the same format your prescriber wants to see — showing your old medication and new medication side by side.
→ Start tracking your stimulant switch free ← → See how prescribers view Titrate reports ←
Also see our guides on stimulant titration timelines, Concerta titration, and medication review prep.
FAQ
Q: How long does it take to know if a new stimulant is working? Stimulant labels describe dose changes at about weekly intervals, and NICE describes a 6-week trial at an adequate dose before deciding a medication hasn't helped enough. A comparison between two medications is more reliable after a few weeks of consistent data on each.
Q: Should I switch classes or just formulations first? It depends on your situation. NICE recommends lisdexamfetamine or methylphenidate as first-line options for adults, and considering a switch to the other after a 6-week trial at an adequate dose that hasn't helped enough. For children, methylphenidate comes first, with lisdexamfetamine considered after a 6-week trial. Whether to try another formulation in the same class first is your prescriber's call.
Q: Can I keep some of my old medication for emergencies? Ask your prescriber or pharmacist what to do with leftover tablets. Stimulant labels warn about misuse and overdose and ask for safe storage and disposal of unused medicine. Taking two stimulants together or extra doses without direction can raise heart rate and blood pressure, so only switch back and forth if your prescriber has planned it.
Q: What if the new medication feels worse on day one? Some people find early side effects ease over the first days, but not everyone does. Severe anxiety, palpitations or a severe headache need a prompt call to your prescriber, and chest pain or fainting needs urgent care. For milder side effects, a week of notes gives your prescriber something concrete to judge.
Q: Do I need to track the same times every day? Yes. Consistency is what makes the data comparable. If you track focus at 9 AM one day and 11 AM the next, the numbers aren't comparable.
Q: What if my old medication was "fine" but not great? That's exactly the situation where a switch helps. "Fine" is not the goal of titration. The goal is the dose and formulation that gives you the best function with the fewest side effects. Data helps you find it.
Q: Can I switch because of cost or insurance? Yes — cost is a legitimate clinical factor. If you need to switch to a generic or a different medication for insurance reasons, use the same tracking approach. If the new option doesn't work as well, the data supports asking for a prior authorization or formulary exception.
Key takeaways
- Switching stimulants is a normal part of ADHD treatment — not a sign that something went wrong.
- The most useful data is a structured before-and-after comparison, not a long description.
- Track the same metrics on both medications so the comparison is valid.
- Common switches include IR to ER, methylphenidate to amphetamine, and brand to generic — each has different expectations.
- Washout is not always needed, but the transition plan should come from your prescriber.
- A one-page report template is usually enough for your prescriber to make a clear decision.
- Titrate automates this report from daily check-ins.
References
- Cortese S, et al. Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis. Lancet Psychiatry. 2018;5(9):727–738.
- NICE guideline NG87 — Attention deficit hyperactivity disorder: diagnosis and management, recommendations 1.7.7–1.7.13, 1.7.21–1.7.22, 1.8.6 and 1.8.9. https://www.nice.org.uk/guidance/ng87
- Vyvanse (lisdexamfetamine) prescribing information, sections 2, 4, 6, 12.3 and 14. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=704e4378-ca83-445c-8b45-3cfa51c1ecad
- Adderall XR (mixed amphetamine salts) prescribing information, sections 2 and 6. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=aff45863-ffe1-4d4f-8acf-c7081512a6c0
- Concerta (methylphenidate extended-release) prescribing information, sections 2.4, 4, 6 and 12.3. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1a88218c-5b18-4220-8f56-526de1a276cd
This article is for educational purposes only. It does not constitute medical advice. Always consult your licensed healthcare provider about medication decisions.